Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2025
出 版 商：XYZ Research
出版日期：2019/11/01
頁 數：112頁
文件格式：PDF
價 格：
USD 3,150 (Single-User License)
USD 6,200 (Global-User License)
USD 6,200 (Global-User License)
In this report,the global paclitaxel market was valued at 78.77 Million USD in 2017 and will reach 161.66 Million USD by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The report is revolving around Paclitaxel active pharmaceutical ingredients.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 was about 31%, and the proportion was decreasing trend from 2012 to 2017.
Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel was sales in Ovarian Cancer, and the consumption proportion was about 46% in 2017.
North America was the largest consumption place, with a consumption market share nearly 53% in 2017. Europe was the second largest consumption place with the consumption market share of 19%, China was also an important sales region for the Paclitaxel.
Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Paclitaxel in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Paclitaxel market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Paclitaxel for each application, including
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The report is revolving around Paclitaxel active pharmaceutical ingredients.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 was about 31%, and the proportion was decreasing trend from 2012 to 2017.
Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel was sales in Ovarian Cancer, and the consumption proportion was about 46% in 2017.
North America was the largest consumption place, with a consumption market share nearly 53% in 2017. Europe was the second largest consumption place with the consumption market share of 19%, China was also an important sales region for the Paclitaxel.
Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Paclitaxel in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Paclitaxel market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Paclitaxel for each application, including
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Paclitaxel Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Natural Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Semi-synthetic Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Paclitaxel Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Paclitaxel Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Paclitaxel Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Paclitaxel Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Paclitaxel Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Paclitaxel Market Assessment by Type
8.1 Asia Pacific Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.2 North America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.3 Europe Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.4 South America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Paclitaxel Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Phyton
9.1.1 Phyton Profiles
9.1.2 Phyton Product Portfolio
9.1.3 Phyton Paclitaxel Business Performance
9.1.4 Phyton Paclitaxel Business Development and Market Status
9.2 ScinoPharm
9.2.1 ScinoPharm Profiles
9.2.2 ScinoPharm Product Portfolio
9.2.3 ScinoPharm Paclitaxel Business Performance
9.2.4 ScinoPharm Paclitaxel Business Development and Market Status
9.3 Novasep
9.3.1 Novasep Profiles
9.3.2 Novasep Product Portfolio
9.3.3 Novasep Paclitaxel Business Performance
9.3.4 Novasep Paclitaxel Business Development and Market Status
9.4 Samyang
9.4.1 Samyang Profiles
9.4.2 Samyang Product Portfolio
9.4.3 Samyang Paclitaxel Business Performance
9.4.4 Samyang Paclitaxel Business Development and Market Status
9.5 Polymed
9.5.1 Polymed Profiles
9.5.2 Polymed Product Portfolio
9.5.3 Polymed Paclitaxel Business Performance
9.5.4 Polymed Paclitaxel Business Development and Market Status
9.6 TAPI (Teva)
9.6.1 TAPI (Teva) Profiles
9.6.2 TAPI (Teva) Product Portfolio
9.6.3 TAPI (Teva) Paclitaxel Business Performance
9.6.4 TAPI (Teva) Paclitaxel Business Development and Market Status
9.7 Fresenius-kabi
9.7.1 Fresenius-kabi Profiles
9.7.2 Fresenius-kabi Product Portfolio
9.7.3 Fresenius-kabi Paclitaxel Business Performance
9.7.4 Fresenius-kabi Paclitaxel Business Development and Market Status
9.8 Huiang biopharma
9.8.1 Huiang biopharma Profiles
9.8.2 Huiang biopharma Product Portfolio
9.8.3 Huiang biopharma Paclitaxel Business Performance
9.8.4 Huiang biopharma Paclitaxel Business Development and Market Status
9.9 Southpharma
9.9.1 Southpharma Profiles
9.9.2 Southpharma Product Portfolio
9.9.3 Southpharma Paclitaxel Business Performance
9.9.4 Southpharma Paclitaxel Business Development and Market Status
9.10 Yunnan Hande
9.10.1 Yunnan Hande Profiles
9.10.2 Yunnan Hande Product Portfolio
9.10.3 Yunnan Hande Paclitaxel Business Performance
9.10.4 Yunnan Hande Paclitaxel Business Development and Market Status
9.11 Hainan Yew Pharm
9.12 Jiangsu Yew Biotechnology
10 World Paclitaxel Market Assessment by Players
10.1 Global Paclitaxel Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Paclitaxel Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Paclitaxel Price (USD/Unit) of Players 2014-2020
10.4 Global Paclitaxel Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Paclitaxel Sales Assessment of Players 2014-2020
11.1.2 North America Paclitaxel Revenue Assessment of Players 2014-2020
11.1.3 North America Paclitaxel Price Assessment of Players 2014-2020
11.1.4 North America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Paclitaxel Sales Assessment of Players 2014-2020
11.2.2 Europe Paclitaxel Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Paclitaxel Price Assessment of Players 2014-2020
11.2.4 Europe Paclitaxel Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Paclitaxel Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Paclitaxel Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Paclitaxel Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Paclitaxel Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Paclitaxel Sales Assessment of Players 2014-2020
11.4.2 South America Paclitaxel Revenue Assessment of Players 2014-2020
11.4.3 South America Paclitaxel Price Assessment of Players 2014-2020
11.4.4 South America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Paclitaxel Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Paclitaxel Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Paclitaxel Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Paclitaxel Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Paclitaxel Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Paclitaxel Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Paclitaxel Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Paclitaxel Sales by Countries/Regions 2014-2020
12.2.2 North America Paclitaxel Revenue by Countries/Regions 2014-2020
12.2.3 North America Paclitaxel Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Paclitaxel Sales by Countries/Regions 2014-2020
12.3.2 Europe Paclitaxel Revenue by Countries/Regions 2014-2020
12.3.3 Europe Paclitaxel Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Paclitaxel Sales by Countries/Regions 2014-2020
12.4.2 South America Paclitaxel Revenue by Countries/Regions 2014-2020
12.4.3 South America Paclitaxel Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Paclitaxel Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Paclitaxel Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Paclitaxel Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Paclitaxel Sales & Revenue Forecast 2021-2026
14.1 World Paclitaxel Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World PaclitaxelSales and Market Share by Regions
14.1.2 World PaclitaxelRevenue and Market Share by Regions
15 Asia Paclitaxel Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Natural Paclitaxel API
15.1.2 Semi-synthetic Paclitaxel API
15.2 Consumption Forecast by Application, 2021-2026
16 North America Paclitaxel Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Natural Paclitaxel API
16.1.2 Semi-synthetic Paclitaxel API
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Paclitaxel Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Natural Paclitaxel API
17.1.2 Semi-synthetic Paclitaxel API
17.2 Consumption Forecast by Application, 2021-2026
18 South America Paclitaxel Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Natural Paclitaxel API
18.1.2 Semi-synthetic Paclitaxel API
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Paclitaxel Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Natural Paclitaxel API
19.1.2 Semi-synthetic Paclitaxel API
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Paclitaxel Price (USD/Unit) Trend 2021-2026
20.2 Global Paclitaxel Gross Profit Trend 2021-2026
21 Conclusion
Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Paclitaxel Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Natural Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Semi-synthetic Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Paclitaxel Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Paclitaxel Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Paclitaxel Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Paclitaxel Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Paclitaxel Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Paclitaxel Market Assessment by Type
8.1 Asia Pacific Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.2 North America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.3 Europe Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.4 South America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Paclitaxel Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Phyton
9.1.1 Phyton Profiles
9.1.2 Phyton Product Portfolio
9.1.3 Phyton Paclitaxel Business Performance
9.1.4 Phyton Paclitaxel Business Development and Market Status
9.2 ScinoPharm
9.2.1 ScinoPharm Profiles
9.2.2 ScinoPharm Product Portfolio
9.2.3 ScinoPharm Paclitaxel Business Performance
9.2.4 ScinoPharm Paclitaxel Business Development and Market Status
9.3 Novasep
9.3.1 Novasep Profiles
9.3.2 Novasep Product Portfolio
9.3.3 Novasep Paclitaxel Business Performance
9.3.4 Novasep Paclitaxel Business Development and Market Status
9.4 Samyang
9.4.1 Samyang Profiles
9.4.2 Samyang Product Portfolio
9.4.3 Samyang Paclitaxel Business Performance
9.4.4 Samyang Paclitaxel Business Development and Market Status
9.5 Polymed
9.5.1 Polymed Profiles
9.5.2 Polymed Product Portfolio
9.5.3 Polymed Paclitaxel Business Performance
9.5.4 Polymed Paclitaxel Business Development and Market Status
9.6 TAPI (Teva)
9.6.1 TAPI (Teva) Profiles
9.6.2 TAPI (Teva) Product Portfolio
9.6.3 TAPI (Teva) Paclitaxel Business Performance
9.6.4 TAPI (Teva) Paclitaxel Business Development and Market Status
9.7 Fresenius-kabi
9.7.1 Fresenius-kabi Profiles
9.7.2 Fresenius-kabi Product Portfolio
9.7.3 Fresenius-kabi Paclitaxel Business Performance
9.7.4 Fresenius-kabi Paclitaxel Business Development and Market Status
9.8 Huiang biopharma
9.8.1 Huiang biopharma Profiles
9.8.2 Huiang biopharma Product Portfolio
9.8.3 Huiang biopharma Paclitaxel Business Performance
9.8.4 Huiang biopharma Paclitaxel Business Development and Market Status
9.9 Southpharma
9.9.1 Southpharma Profiles
9.9.2 Southpharma Product Portfolio
9.9.3 Southpharma Paclitaxel Business Performance
9.9.4 Southpharma Paclitaxel Business Development and Market Status
9.10 Yunnan Hande
9.10.1 Yunnan Hande Profiles
9.10.2 Yunnan Hande Product Portfolio
9.10.3 Yunnan Hande Paclitaxel Business Performance
9.10.4 Yunnan Hande Paclitaxel Business Development and Market Status
9.11 Hainan Yew Pharm
9.12 Jiangsu Yew Biotechnology
10 World Paclitaxel Market Assessment by Players
10.1 Global Paclitaxel Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Paclitaxel Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Paclitaxel Price (USD/Unit) of Players 2014-2020
10.4 Global Paclitaxel Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Paclitaxel Sales Assessment of Players 2014-2020
11.1.2 North America Paclitaxel Revenue Assessment of Players 2014-2020
11.1.3 North America Paclitaxel Price Assessment of Players 2014-2020
11.1.4 North America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Paclitaxel Sales Assessment of Players 2014-2020
11.2.2 Europe Paclitaxel Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Paclitaxel Price Assessment of Players 2014-2020
11.2.4 Europe Paclitaxel Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Paclitaxel Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Paclitaxel Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Paclitaxel Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Paclitaxel Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Paclitaxel Sales Assessment of Players 2014-2020
11.4.2 South America Paclitaxel Revenue Assessment of Players 2014-2020
11.4.3 South America Paclitaxel Price Assessment of Players 2014-2020
11.4.4 South America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Paclitaxel Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Paclitaxel Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Paclitaxel Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Paclitaxel Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Paclitaxel Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Paclitaxel Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Paclitaxel Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Paclitaxel Sales by Countries/Regions 2014-2020
12.2.2 North America Paclitaxel Revenue by Countries/Regions 2014-2020
12.2.3 North America Paclitaxel Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Paclitaxel Sales by Countries/Regions 2014-2020
12.3.2 Europe Paclitaxel Revenue by Countries/Regions 2014-2020
12.3.3 Europe Paclitaxel Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Paclitaxel Sales by Countries/Regions 2014-2020
12.4.2 South America Paclitaxel Revenue by Countries/Regions 2014-2020
12.4.3 South America Paclitaxel Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Paclitaxel Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Paclitaxel Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Paclitaxel Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Paclitaxel Sales & Revenue Forecast 2021-2026
14.1 World Paclitaxel Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World PaclitaxelSales and Market Share by Regions
14.1.2 World PaclitaxelRevenue and Market Share by Regions
15 Asia Paclitaxel Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Natural Paclitaxel API
15.1.2 Semi-synthetic Paclitaxel API
15.2 Consumption Forecast by Application, 2021-2026
16 North America Paclitaxel Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Natural Paclitaxel API
16.1.2 Semi-synthetic Paclitaxel API
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Paclitaxel Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Natural Paclitaxel API
17.1.2 Semi-synthetic Paclitaxel API
17.2 Consumption Forecast by Application, 2021-2026
18 South America Paclitaxel Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Natural Paclitaxel API
18.1.2 Semi-synthetic Paclitaxel API
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Paclitaxel Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Natural Paclitaxel API
19.1.2 Semi-synthetic Paclitaxel API
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Paclitaxel Price (USD/Unit) Trend 2021-2026
20.2 Global Paclitaxel Gross Profit Trend 2021-2026
21 Conclusion
